Mead Johnson NEC Baby Formula Lawsuit, Were You Affected? — Inman v. Mead Johnson & Company, LLC, et al., No. 1:22-cv-03737
If your premature baby developed necrotizing enterocolitis after being fed Enfamil Premature formula in the NICU — you were not imagining a connection. Mead Johnson is now on trial in federal court in Chicago, facing claims from Alexis Inman that the company’s practice violated its duty to warn parents and doctors about that exact risk. Here is what that means for you.
Mead Johnson NEC Lawsuit — Key Facts
| Category | Details |
| Lawsuit Filed | 2022 (originating case no. 22 C 3737); consolidated into MDL No. 3026 |
| Defendant | Mead Johnson & Company, LLC and Mead Johnson Nutrition Company, subsidiaries of Reckitt |
| Alleged Harm | Necrotizing enterocolitis (NEC) in a premature infant fed Enfamil Premature formula |
| Law Alleged | Products liability — failure to warn and design defect |
| Who Is Affected | Families of premature infants fed Enfamil Premature in a NICU who developed NEC |
| Court & Case Number | U.S. District Court, N.D. Illinois — No. 1:22-cv-03737, MDL No. 3026 |
| Current Stage | Bellwether trial before a jury, underway since August 17, 2026 |
| Lead Plaintiff Deadline | Not applicable — this is an MDL, not a class action; individual families should ask an attorney about their state’s statute of limitations instead |
| Settlement Status | No global settlement reached; no dollar figure at stake yet |
| Last Updated | August 22, 2026 |
Who Is Mead Johnson and Why Are They Being Sued for NEC?
Mead Johnson makes Enfamil, including a cow’s-milk-based formula marketed specifically for premature infants in neonatal intensive care units. That specialty positioning put its formula directly in front of the exact population researchers say faces the highest NEC risk. The lawsuit claims Mead Johnson knew about that risk for years and continued marketing Enfamil Premature to NICUs without adequate warning.
What Did Mead Johnson Do to Premature Infants and Their Families?
Alexis Inman gave birth to twin sons, Daniel and Deyvon, on May 12, 2020, at 29 weeks gestation. Daniel weighed less than two pounds. According to court filings, he was fed Enfamil Premature formula, developed NEC, and died from the disease and related shock later that year. Inman’s lawsuit claims Mead Johnson failed to warn her and her healthcare providers about the alleged NEC risk, and that safer, feasible alternative formulations existed.
Products liability law — the legal theory that a company can be held responsible for a product that’s unreasonably dangerous or poorly labeled — is what plaintiffs are relying on here. It’s the same theory driving the broader Abbott baby formula NEC litigation, where hundreds of similar claims remain active.
Plaintiffs’ counsel calls this trial a step toward accountability for families who’ve waited years for a case to reach a jury.
That’s not just legal language. If your family has a similar story and hasn’t filed anything yet, the clock on your state’s statute of limitations may already be running.
Are You Part of the Mead Johnson NEC Lawsuit?
Here’s exactly how to know if this case includes you.
- Families whose premature infant was fed Enfamil Premature or a similar cow’s-milk-based Mead Johnson formula in a NICU
- Infants who were later diagnosed with necrotizing enterocolitis
- Parents who received no warning from Mead Johnson, hospital staff, or product labeling about elevated NEC risk tied to formula feeding
- Anyone whose child’s medical records show a transition from breast milk or donor milk to Enfamil Premature before NEC symptoms began
You likely don’t have a claim here if your child’s NEC diagnosis involved a different formula brand, or if a doctor’s records point to causes unrelated to feeding method.

Mead Johnson NEC Claims Outside Illinois — Are You Still Covered?
This is a federal MDL, not a state-specific case. Families nationwide have filed claims that were transferred into MDL No. 3026 in the Northern District of Illinois, regardless of where the harm occurred — though a handful of related cases are also proceeding separately in state courts, including one already resolved in Mead Johnson’s favor in Missouri.
Not sure if you’re part of the Mead Johnson NEC lawsuit? A free consultation with a product liability attorney can help you understand your options.
Did your premature baby develop NEC after being switched to Enfamil Premature formula in the NICU? Then this case is about your family too.
What Are Mead Johnson NEC Families Asking the Court to Award?
No money yet. No claim form yet. The Inman trial, and the broader MDL, involves individual lawsuits seeking compensatory damages for medical costs, loss, and suffering — the exact amount is up to the jury, not a pre-set fund.
What Could Mead Johnson NEC Families Receive If Cases Go to Trial or Settle?
Impossible to predict with any real number. Past NEC verdicts have ranged widely — a $60 million 2024 Illinois jury verdict against Mead Johnson, an April 2026 $70 million verdict against Abbott — while Mead Johnson won a Missouri state court NEC trial in early July 2026, just weeks before this federal case opened. Same disease, same science dispute, different juries, opposite results. Talk to a product liability attorney about how these outcomes might apply to your situation.
What Should Mead Johnson NEC Families Do Right Now?
- Most families are not automatically included — unlike a class action, you need to file your own individual lawsuit to join the roughly 825 cases already pending in MDL No. 3026
- Save these documents now: NICU feeding logs, discharge summaries, NEC diagnosis and surgical records, and any formula product packaging or lot numbers
- Document when your child was switched from breast milk or donor milk to Enfamil Premature, and how soon symptoms followed
- Ask an attorney about your state’s statute of limitations — there’s no MDL-wide lead plaintiff deadline here, but individual filing windows do close
- Monitor the docket in Inman v. Mead Johnson & Company, LLC, et al., No. 1:22-cv-03737, in the Northern District of Illinois
- Consider the individual claim option now, while the case is active and evidence is fresh, rather than waiting for a possible future settlement
Mead Johnson NEC Lawsuit — Full Timeline
| Milestone | Date |
| MDL No. 3026 established | April 8, 2022 |
| Daniel Inman born; NEC onset | May 12, 2020 |
| Daniel Inman’s death | 2020 (exact date UNVERIFIED) |
| Inman lawsuit filed | 2022 (exact filing date UNVERIFIED) |
| Summary judgment denied for Mead Johnson | May 8, 2026 |
| Mead Johnson wins related Missouri state trial | Reported July 2, 2026 |
| Federal bellwether trial begins | August 17, 2026 |
| Next scheduled hearing | UNVERIFIED — next Abbott bellwether reportedly expected in October 2026 |
| Expected resolution | UNVERIFIED — depends on jury verdict and any appeal |
Mead Johnson NEC — Frequently Asked Questions, No. 1:22-cv-03737
Is there a class action lawsuit against Mead Johnson for NEC right now?
Not a class action. Cases are consolidated for pretrial purposes in MDL No. 3026 before Judge Rebecca Pallmeyer in the Northern District of Illinois, but each family’s case — including Inman v. Mead Johnson, No. 1:22-cv-03737 — is tried on its own.
Do I need to do anything right now to be part of the Mead Johnson lawsuit?
Yes, if you haven’t filed yet. Unlike a class action settlement, there’s no automatic inclusion — families need to file their own product liability lawsuit to join the roughly 825 cases pending in MDL No. 3026.
When will the Mead Johnson NEC case settle?
No global settlement has been reached. The Inman bellwether trial, underway since August 17, 2026, is expected to influence settlement talks regardless of which side wins.
Can I file my own lawsuit against Mead Johnson instead of joining the MDL?
You can file an individual suit; new NEC cases against Mead Johnson are typically transferred into MDL No. 3026 for pretrial proceedings before returning to a home court for trial if they don’t settle.
How will I find out if the Mead Johnson lawsuit settles?
MDL No. 3026 filings are public through PACER, and the law firms representing NEC families, including Levin Papantonio, typically publish updates if a broader settlement is announced.
What does “bellwether trial” mean for the Mead Johnson case and why does the deadline matter?
A bellwether trial tests how one jury weighs the evidence in a representative case. The Inman verdict won’t decide other families’ cases directly, but it can shift how both sides value settling versus continuing to trial — which is why timing your own filing matters.
What specific claims does Mead Johnson allegedly face in the Inman lawsuit?
The complaint alleges failure to warn medical providers and parents about NEC risk, plus a design defect claim that safer, feasible alternative formulations of Enfamil Premature existed.
How much could Mead Johnson NEC families get if this case settles or goes to verdict?
There’s no set number. Past verdicts have ranged from a $60 million 2024 Illinois jury award against Mead Johnson to a $70 million April 2026 verdict against Abbott, while Mead Johnson won a Missouri state NEC trial in July 2026 — proof the outcome genuinely depends on the jury.
Sources Used in This Mead Johnson NEC Article
- U.S. District Court, Northern District of Illinois — Order Denying Summary Judgment, Inman v. Mead Johnson & Company, LLC, et al., No. 1:22-cv-03737, filed May 8, 2026 (via Courthouse News): https://www.courthousenews.com/wp-content/uploads/2026/05/formula-may-have-been-cause-of-infant-death.pdf
- Levin Papantonio (Plaintiffs’ Co-Lead Counsel) — “First Federal NEC Baby Formula Bellwether Trial Begins Against Mead Johnson,” Aug. 17, 2026: https://levinlaw.com/newsroom/first-federal-nec-baby-formula-bellwether-trial-begins-against-mead-johnson/
- Business Wire (Levin Papantonio press release) — “Trial Set in NEC Multidistrict Litigation Against Reckitt Benckiser’s Mead Johnson Led by Levin Papantonio,” Mar. 5, 2026: https://www.businesswire.com/news/home/20260305466625/en/Trial-Set-in-NEC-Multidistrict-Litigation-Against-Reckitt-Benckiser%E2%80%99s-Mead-Johnson-Led-by-Levin-Papantonio
Researched and written by Israr Ahmad, legal content researcher and founder of AllAboutLawyer.com. All facts verified against the court’s May 8, 2026 order and Levin Papantonio’s official case filings on August 22, 2026. Last Updated: August 22, 2026.
This article is for informational purposes only and does not constitute legal advice. Laws vary by state and individual circumstances differ. For advice about your specific situation, consult a qualified attorney.
About the Author
Israr Ahmad is a legal content researcher with 4+ years of experience covering class action settlements and consumer rights cases. He has researched and published coverage of 2,500+ settlements using verified court records, settlement administrator filings, and government sources. Learn more about Israr.
